Almost every woman asks me the same question before she asks anything else. Is hormone therapy safe?
Here is my answer in short. For a woman who is a candidate and has no contraindications, yes, and the research supports it.
Most of the fear traces to one study, published in 2002, that used synthetic medications. Later analysis traced the harm to a specific synthetic drug given to older women, not to hormones themselves. The same trial's estrogen-only group saw no rise in breast cancer at all.
In November 2025 the FDA reached the same conclusion and began removing its strongest warnings from estrogen-containing hormone therapy.
Let me show you why I can say all of that with confidence.
What happens when a woman brings me this fear
When a woman brings the breast-cancer fear into my office, I do one thing before anything else. I walk her through the Women's Health Initiative and break the study down, simply, piece by piece: what was tested, who was tested, and what was found.
Once the headline "hormones cause cancer" turns back into a study she understands, she hears everything after it differently. Her risk has not changed in that conversation. Her understanding has.
So let me do for you what I do for her.
What the study tested
The trial tested two synthetic medications in postmenopausal women, and in 2002 one of its arms was stopped early over a breast-cancer signal. The headlines were blunt, prescriptions fell by more than half within a year, and a whole field of medicine went quiet.
Two details rarely made those headlines.
The first detail is the drug. The women were not taking the hormones a body makes. They took conjugated equine estrogens, a mix of estrogens derived from horse urine, paired with a synthetic progestin called medroxyprogesterone acetate. These are patented medications shaped to resemble hormones closely enough to act on the body, and their structure differs from the hormones a woman produces.
The second detail is who the women were. The average participant was 63 years old and more than a decade past menopause when she started.
What the two arms found
The trial ran two arms, and they pointed in opposite directions. Women with a uterus took the estrogen combined with the synthetic progestin, and that group carried the breast-cancer signal that made the news. Women who had had a hysterectomy took the estrogen alone.
The estrogen-alone group showed no increase in breast cancer, and over longer follow-up their risk went down. The estrogen-alone findings held for more than a decade after the women stopped treatment, with fewer cancers and fewer deaths from them.
Same estrogen, same trial, same research team. The variable that tracked with the breast-cancer signal was the synthetic progestin. Later analysis of the two arms confirmed the pattern of opposite effects on incidence.
Those women were harmed, and I do not wave that away. The harm came from that specific synthetic drug, not from hormone replacement itself, and the profession turned one drug's record into a blanket warning against hormones.
Why age and balance belong in the story
Does the age of those women matter? I think it plays a large part, and here is the piece most explanations skip.
During the change, most women produce plenty of estrogen and not enough progesterone. Estrogen drives tissue to grow, and progesterone is the brake on that growth. A woman can develop breast cancer at any age, and the risk climbs through that transition because the body is unprotected. Estrogen runs high, sleep often runs short, stress runs high, and there is no brake on any of it.
The women in the trial were then handed a drug that accelerated estrogen's effect on tissue. I think the age and the drug go hand in hand, and both point at the same lesson. What matters is the balance among your hormones, and whether the brake is present, in the form your body recognizes.
Why the molecule matters
The lesson about form is the reason I work with bioidentical hormones. A bioidentical hormone shares the exact molecular structure of the hormone your body already makes, so it fits the cell the way a key fits a lock. The body reads the signal it has read your whole life. A synthetic hormone is shaped differently, and it can act in ways your own hormone does not.
Progesterone is the clearest case. When I replace what the body has stopped making, I use the molecule the body recognizes, and I balance estrogen with progesterone so the brake stays on the system. That pairing sits at the center of hormone optimization as I practice it.
What has changed since 2002
The evidence caught up.
In November 2025 the FDA moved to remove its boxed warnings from estrogen-containing menopausal hormone therapy, the warnings tied to cardiovascular disease, breast cancer, and probable dementia. The agency acted after a comprehensive review found the original reading of the risk overstated. A narrower warning for endometrial cancer stays in place for estrogen-only products, one of the reasons balance and screening matter.
The same review pointed at timing. For women who begin within about ten years of menopause, the described benefits reach past symptom relief, to lower all-cause mortality and fewer fractures. For the woman who starts near her transition, timing moves to her side.
I held this position for years before the label caught up. I tell you about the label so the fear you walked in with has somewhere accurate to stand.
What safe means in my practice
A study answers a question about a population. You are asking about your body, so I answer with your data.
What am I ruling out before you start? Your risk, and what your body is doing, so nothing goes wrong down the road that I was not expecting because I did not dig deep enough. Every woman who wants hormone therapy starts with a comprehensive panel, and I screen for the conditions that would make me pause or say no.
I also suggest a test called the DUTCH test to every woman I treat. The DUTCH test tells me which pathway your body pushes your hormones down, so I know what to watch out for and what I need to learn more about before we build your plan. It makes you more individual to me, and that makes your treatment safer.
Delivery follows the same logic of control. I use routes I can adjust, so your dose keeps pace with your labs and your life. I do not use pellets. Once a pellet is placed the dose cannot be changed, so a woman rides high early and fades late while her labs ask for a steady level.
The question worth bringing to a clinician
So, is hormone therapy safe? For the right woman, screened and monitored, yes, and the study that taught a generation to fear it was misread for most of that time.
When a woman in my office understands the study, the fear loses its grip, and a better question takes its place.
Which hormone, in which form, is right for my body? How will it be balanced, watched, and adjusted over time? Ask that of anyone you trust with your hormones, including me.
Safety was never a property of the word "hormones." It lives in those specifics.
The specifics are knowable, and knowing them is the whole point of doing this carefully.